COCRYSTAL PHARMA INC's ticker is COCP and the CUSIP is 19188J300. A total of 32 filers reported holding COCRYSTAL PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $53,000 | -29.3% | 182,708 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $75,000 | -26.5% | 182,708 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $102,000 | -14.3% | 182,708 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $119,000 | -38.0% | 182,708 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $192,000 | -16.9% | 182,708 | -1.1% | 0.01% | -20.0% |
| Q2 2021 | $231,000 | -14.1% | 184,708 | -4.6% | 0.01% | -23.1% |
| Q1 2021 | $269,000 | -2.2% | 193,708 | -4.2% | 0.01% | -13.3% |
| Q4 2020 | $275,000 | +129.2% | 202,208 | +57.3% | 0.02% | +114.3% |
| Q3 2020 | $120,000 | -38.5% | 128,563 | 0.0% | 0.01% | -46.2% |
| Q2 2020 | $195,000 | +114.3% | 128,563 | 0.0% | 0.01% | +85.7% |
| Q1 2020 | $91,000 | +279.2% | 128,563 | +161.6% | 0.01% | +250.0% |
| Q4 2019 | $24,000 | -75.8% | 49,144 | +1.3% | 0.00% | -75.0% |
| Q3 2019 | $99,000 | – | 48,499 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 6,110,657 | $7,638,000 | 1.08% |
| Altium Capital Management LP | 776,000 | $970,000 | 0.22% |
| Alyeska Investment Group, L.P. | 2,750,100 | $3,438,000 | 0.04% |
| Virtu Financial LLC | 116,625 | $146,000 | 0.01% |
| Parallel Advisors, LLC | 184,708 | $231,000 | 0.01% |
| Renaissance Technologies | 2,593,933 | $3,242,000 | 0.00% |
| CIM, LLC | 11,000 | $12,000 | 0.00% |
| Western Wealth Management, LLC | 19,115 | $24,000 | 0.00% |
| Mariner, LLC | 200,055 | $250,000 | 0.00% |
| BRIGHTON JONES LLC | 36,000 | $45,000 | 0.00% |